semaglutide hagerstown md Microdose GLP-1 Weight Loss Program |

Diabetes 59(April)

Zepbound (tirzepatide) and Wegovy (semaglutide) are designed for adults who are overweight or have obesity, and both have proven benefits, but they also have important differences that are important to understand

Liraglutide achieved an 8% weight loss over 56 weeks (Pi-Sunyer et al., 2015), while semaglutide resulted in a 15% reduction over two years (Wharton et al., 2023)

The first is a large-cap pharma company with a significant existing presence in anti-diabetic therapy, where this category already contributes close to 10% of annual revenues

it can help those with obesity

In addition to managing blood glucose levels, GLP-1 medications have been shown to support weight loss by reducing hunger and enhancing satiety